Format

Send to

Choose Destination
Drug Discov Today. 2014 Jul;19(7):830-3. doi: 10.1016/j.drudis.2013.12.001. Epub 2013 Dec 8.

Course fees and academic ranking: insights from the IMI EMTRAIN on-course® database.

Author information

1
EMTRAIN, Centre for Integrated Genomic Medical Research, The University of Manchester, Manchester, UK. Electronic address: tony.payton@manchester.ac.uk.
2
EMTRAIN, Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
3
EMTRAIN, Centre for Integrated Genomic Medical Research, The University of Manchester, Manchester, UK.
4
EMTRAIN, PharmaTrain, R&D Science Relations, AstraZeneca Pharmaceuticals, Macclesfield, UK.

Abstract

The Innovative Medicines Initiative (IMI) funded project on-course® (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course®, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities.

PMID:
24325828
DOI:
10.1016/j.drudis.2013.12.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center